Imaging/Diagnostics News

IDx-DR, an autonomous artificial intelligence-based diagnostic system for the detection of diabetic retinopathy in primary care offices, outperformed all prespecified superiority endpoints of sensitivity, specificity and imageability rates, according to the results of a clinical trial.

Ultra-widefield imaging was found to have “moderate to substantial agreement” with ETDRS 7-field imaging to determine the severity of diabetic retinopathy.

CHICAGO — Steven Silverstein, MD, discusses pattern and flicker electrophysiology devices (Diopsys) for diagnosing, monitoring and treating patients with glaucoma and retinopathies at the American Academy of Ophthalmology meeting here.

CHICAGO — At the Ophthalmology Innovation Summit at AAO, Kfir Azoulay, head of corporate strategy at Heidelberg Engineering, discusses the launch of the company’s OCT angiography module for the Spectralis as well as other innovations taking place.

CHICAGO — David S. Chin Yee, MD, discusses best practices in using the ForeseeHome device to monitor AMD patients' transition from dry to wet forms of the disease at the American Academy of Ophthalmology meeting here.

CHICAGO — Artificial intelligence, deep learning systems and automated diagnostic systems can improve ophthalmologic care for patients and provide help for overburdened ophthalmologists.

CHICAGO — Ellex Medical Lasers is previewing its next-generation ultrasound solution Eye Prime at the American Academy of Ophthalmology meeting here, according to a press release.

Web Vision Technologies announced a plan to develop a diagnostic device to be deployed on spacecraft for comprehensive vision testing and evaluation and guiding medical interventions of astronauts who experience vision problems on potential deep space missions.

IDx reached an exclusivity agreement with Topcon to sell its artificial intelligence-based diagnostic system with the Topcon NW400 robotic fundus camera.

A portable handheld adaptive optics scanning laser ophthalmoscope enables cellular level imaging near the fovea of the retina, according to researchers who engineered and tested the device in a human trial.